+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ventrolateral periaqueductal gray lesion attenuates nociception but does not change anxiety-like indices or fear-induced antinociception in mice



Ventrolateral periaqueductal gray lesion attenuates nociception but does not change anxiety-like indices or fear-induced antinociception in mice



Behavioural Brain Research 219(2): 248-253



The exposure of rodents to an open elevated plus-maze (oEPM: four open arms raised from the floor) elicits naloxone-insensitive antinociception. Midazolam infusion into the dorsal portion of the periaqueductal gray (dPAG), a structure of the descending inhibitory system of pain, failed to alter oEPM-induced antinociception. Chemical lesion of dorsomedial and dorsolateral PAG attenuated defensive behavior in the standard EPM (sEPM), an animal model of anxiety, but failed to change oEPM-induced antinociception. The present study investigated the effects of bilateral lesion, with the injection of NMDA (N-methyl-D-aspartic acid), of the ventrolateral column of PAG (vlPAG) (i) on nociceptive response induced by 2.5% formalin injected into the right hind paw (nociception test) in mice exposed to the enclosed EPM (eEPM: four enclosed arms - a non-aversive situation) or to the oEPM and (ii) on anxiety indices in mice exposed to the sEPM without prior formalin injection. Results showed that oEPM-induced antinociception was not altered by lesion of vlPAG. Nevertheless, the lesion reduced the nociceptive response in mice exposed to the eEPM and increased general locomotor activity during the eEPM and oEPM exposure. Furthermore, vlPAG lesion did not alter anxiety-like indices in mice exposed to the sEPM. The results suggest that vlPAG does not play a role in oEPM-induced antinociception or in defensive reactions assessed in the sEPM. Moreover, vlPAG inactivation induces pain inhibition in mice not exposed to an aversive situation and seems to increase general activity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056861715

Download citation: RISBibTeXText

PMID: 21238499

DOI: 10.1016/j.bbr.2011.01.012


Related references

Lesion of the ventral periaqueductal gray reduces conditioned fear but does not change freezing induced by stimulation of the dorsal periaqueductal gray. Learning and Memory 8(3): 164-169, 2001

Lesion of the ventral periaqueductal gray reduces conditioned fear but does not change freezing induced by electrical stimulation of the dorsal periaqueductal gray. Society for Neuroscience Abstracts 27(2): 1962, 2001

Selective inhibition of the NOP receptor in the ventrolateral periaqueductal gray attenuates the development and the expression of tolerance to morphine-induced antinociception in rats. Peptides 31(4): 696-700, 2010

Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice. Behavioural Brain Research 292: 547-554, 2016

Interplay between 5-HT 2C and 5-HT 1A receptors in the dorsal periaqueductal gray in the modulation of fear-induced antinociception in mice. Neuropharmacology 140: 100-106, 2018

Rat exposure in mice with neuropathic pain induces fear and antinociception that is not reversed by 5-HT2C receptor activation in the dorsal periaqueductal gray. Behavioural Brain Research 307: 250-257, 2017

Antinociception induced by stimulation of ventrolateral periaqueductal gray at the freezing threshold is regulated by opioid and 5-HT2A receptors as assessed by the tail-flick and formalin tests. Pharmacology Biochemistry & Behavior 75(2): 459-466, 2003

Pharmacological evidence for a periaqueductal gray-nucleus raphe magnus connection mediating the antinociception induced by microinjecting carbachol into the dorsal periaqueductal gray of rats. Brain Research 827(1-2): 152-159, May 8, 1999

Effects of chemical blockade of the ventrolateral periaqueductal gray on conditioned fear and recovery after fear Cardiovascular and behavioral components. Society for Neuroscience Abstracts 27(2): 2216, 2001

Injections of corticotropin releasing factor into the ventrolateral periaqueductal gray produce antinociception. Society for Neuroscience Abstracts 20(1-2): 766, 1994

Projections from the ventrolateral periaqueductal gray to noradrenergic cells in the brainstem that are involved in modulating nociception. Society for Neuroscience Abstracts 23(1-2): 158, 1997

Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Research 821(1): 224-230, March 6, 1999

Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray. Pain 121(1-2): 94-104, 2006

Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat. European Journal of Neuroscience 44(9): 2667-2672, 2016

Estrus phase differences in female rats in morphine antinociception elicited from the ventrolateral periaqueductal gray. International Journal of Neuroscience 117(6): 811-822, 2007